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Edited by Gerrit van MeerAbstract Many ABC proteins are functional in cellular lipid
transport in various diﬀerent manners. ABCA7 is a full-size
ABC transporter, the physiological function of which is unknown
to date. This is a protein that shows the highest homology known
to ABCA1, an essential molecule for producing of plasma high-
density lipoprotein (HDL), and in fact it mimics ABCA1 to
mediate the production of HDL from cellular lipid when trans-
fected in vitro. It is therefore rational to assume that ABCA7
plays a relevant role in regulating of lipid metabolism. However,
the ABCA7 expression proﬁle is distinct from that of ABCA1,
with respect to tissue-speciﬁc distribution and response to some
reagents, presumably because of diﬀerent transcriptional and
posttranscriptional regulation. Potential roles and functions of
ABCA7 in lipid homeostasis are discussed, especially in relation
to HDL metabolism, based on available publications.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A-I1. Introduction
ABCA7 is one of the ABC family proteins that is a so-called
full-size ABC transporter consisting of two sets of the multiple
membrane-spanning domains plus the Walker motifs for the
ATP interaction [1]. ABCA7 is a protein having the highest
homology known to ABCA1, one of the essential proteins for
cholesterol homeostasis. Mammalian ABCA1 plays an impor-
tant role in cellular and body cholesterol homeostasis, by medi-
ating production of plasma high-density lipoprotein (HDL)
with helical apolipoprotein and cellular lipid and thereby regu-
lating cellular cholesterol release [2,3]. Therefore, it is assumed
that ABCA7 may also function in lipid or cholesterol metabo-
lism. When ABCA7 was transfected in vitro, it in fact mediates
production of HDL upon the interaction of the cells with heli-
cal amphiphilic surface-active proteins such as apolipoprotein
(apo) A-I, apoA-II and serum amyloid A protein, except that
relative release of cholesterol to phospholipid is much lower
than the ABCA1-mediated reaction [4–9, Abe-Dohmae et al.
manuscript submitted]. However, deﬁciency of ABCA7 may
not markedly alter the plasma HDL level or other lipid/choles-
terol metabolism [8] and the tissue-speciﬁc expression proﬁle is
substantially diﬀerent from that of ABCA1 [10–12]. Thus, the*Corresponding author. Fax: +81 52 841 3480.
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doi:10.1016/j.febslet.2005.12.029physiological function of ABCA7 is still essentially unknown.
In this article, we intend to review the up-to-date information
on ABCA7 and discuss potential functions of this protein based
on the available published results.2. Structure of ABCA7
Human [10], mouse [11], and rat [12] ABCA7 cDNAs have
been cloned from macrophages, thymus, and platelets, respec-
tively, and the clones exhibited high homology to other ABC
transporters. The cDNAs of ABCA7 encode proteins of 2146
(human) [10], 2159 (mouse) [11], and 2170 (rat) [12] amino
acids, respectively. Human ABCA7 protein shows the highest
homology known to human ABCA1 (54%) and human
ABCA4 (49%) [10]. Interspecies identity of protein sequences
of ABCA7 is 79% between human and mouse, less than that
of ABCA1 (95%) and ABCA4 (88%) genes [11]. ABCA7 pro-
teins of all the three species contain two sets of ATP-binding
cassettes including Walker A and B motifs, which are present
in many ATP-utilizing proteins, and a Walker C signature mo-
tif, characteristic to the full-size ABC transporters [1]. Interest-
ingly, a cDNA of human ABCA7 has been also cloned from
thymus [13] as a gene encoding SS-N, an epitope of an autoan-
tigen related to Sjo¨gren’s syndrome.
A splicing variant mRNA (type II mRNA) of humanABCA7
has been detected [5]. The new exon found between exon 5 and
6, which was designated as exon 5B, contained two terminal co-
dons and another translation initiation codon. Thus type II
mRNA produces ABCA7 protein containing 28 novel N-termi-
nal amino acids instead of the 1–166 amino acid sequence in full
length (type I) ABCA7. Tissue-speciﬁc alternative splicing was
detected by RT-PCR. Among the tissues examined, expression
of type II mRNA was higher than type I mRNA in spleen, thy-
mus, lymph node, and trachea, while type I mRNAwas equal to
or more than type II mRNA in bone marrow and brain [5]. In
this review, type I ABCA7 and type II ABCA7 are designated
as ABCA7 and type II ABCA7, respectively.
In Western blotting analysis, protein bands of diﬀerent
molecular weight have been demonstrated in some tissues from
mouse [4] and rat [12], suggesting alternative splicing and/or
alternative posttranslational modiﬁcations.3. Clinical relevance and gene disruption
No genetic defect was reported on the human ABCA7 gene.
A high-density single nucleotide polymorphism (SNP) map ofblished by Elsevier B.V. All rights reserved.
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identiﬁed 67 SNPs at the ABCA7 locus [14]. No association
has been indicated between variations and pathological pheno-
types to date.
Analysis of human ABCA7 gene structure revealed that the
ABCA7 gene localizes in tandem with the minor histocompat-
ibility antigen HA-1 on the same strand [15]. Studies on SNPs
in the HA-1 gene demonstrated that the incidence of an allele
(168 His) was lower in the patients with Sjo¨gren’s syndrome
than controls [16]. In addition, SS-N is a part of the ﬁrst extra-
cellular domain of ABCA7 [13] and an antibody against this
domain reacted to inﬁltrating plasma cells in salivary glands
from the patients of this disease, but not in those from non-
speciﬁc sialoadenitis patients [17]. The pathophysiological sig-
niﬁcance of these observations is unclear to date.
A homozygous ABCA7 knockout mouse was found embry-
onic lethal [7], but one other group reported generation of
ABCA7 null mice [8]. No remarkable phenotype was observed
in these animals, except that white adipose tissue mass was
about 50% less and the serum HDL cholesterol level was some-
what but signiﬁcantly lower than that of the wild type control
only in the female mice at the age of 10-weeks. No such change
was detected in the male knockout mice [8]. No diﬀerence was
shown for apoA-I and apoE protein levels in the HDL or
serum free fatty acid proﬁle [8]. Production of the homozygous
mouse by intercrossing of the heterozygotes was at the ex-
pected rate, and its development, including feeding behavior
and weight gain up to 10 weeks, was normal [8]. These results
indicate that ABCA7 deﬁciency in human might be also
asymptomatic and no patient may have been found even if
present.
There are no data available for hormone-dependent events
and fertility of the knockout mouse. Analysis of gonadal ste-
roid hormone would be helpful to address these issues.4. Expression pattern
4.1. Tissue distribution
The ABCA7 gene is widely expressed both in adult and
embryonic tissues in human [5,10], mouse [11], and rat [12].
The tissue distribution proﬁle of ABCA7 is diﬀerent from that
of ABCA1. While the latter is ubiquitously expressed and espe-
cially abundant in the liver [2], RNA dot blot analysis of hu-
man tissues demonstrated the highest expression of ABCA7
in the thymus and predominant expression in other immune
and hematopoietic tissues (spleen, lymph node, peripheral leu-
kocytes, and bone marrow) [10]. In addition to these tissues,
Northern blot analysis [5] showed high-level mRNA expres-
sion in the brain. In mouse, a similar expression pattern was
observed by Northern blotting showing the highest mRNA
levels in myelolymphatic tissues [11]. mRNA was also detected
in the brain, adrenal glands, and uterus [11]. In the brain, neu-
ronal staining was demonstrated by in situ hybridization anal-
ysis [8].
Data are limited for the tissue distribution of ABCA7 pro-
tein in human, but the expression pattern of ABCA7 protein
in mouse and rat is almost identical to the mRNA expression.
In mouse, the ABCA7 protein level is high in the spleen, lung,
adrenal glands, and brain, moderate in the peripheral macro-
phages and lymphocytes, and low in the liver [4]. High-level
expression of ABCA7 protein was also detected in platelets[4], erythrocytes [4], and in the white adipose tissue [8]. ABCA7
protein was highly expressed in platelets in rat, and much
lower in lymphocytes, erythrocytes, brain, and ovary [12].
Analysis of the ABCA7 expression in human peripheral blood
cells gave controversial results. One article reported expression
of ABCA7 in lymphocytes, granulocytes, and monocytes [10]
but the other claimed the failure of detection of ABCA7 pro-
tein in peripheral blood cells in spite of the mRNA expression
[5].
4.2. Subcellular localization
Little is known concerning the subcellular localization of
endogenous ABCA7 protein. Immunoﬂuorescence confocal
microscopy with rabbit anti-mouse ABCA7 antibody detected
no signal at the plasma membrane but in the intracellular
space in peritoneal macrophages [7]. The same authors de-
scribed positive staining of the brush border membrane in
proximal tubules of the kidney [7], but the background in
the control staining was signiﬁcant [7] and expression levels
of ABCA7 mRNA and protein were both reportedly low in
the kidney [4,8,11,12].
ABCA7 protein resulting from transfected cDNA (wild type,
GFP-tagged, and Flag-tagged) was localized predominantly in
the plasma membrane but was also detected in the intracellular
membranes [4–7,12]. When expressed in CHO cells, rat
ABCA7 with no tag and that with GFP tag at the N-terminus
were both detected mainly in the plasma membrane, while
ABCA7 with GFP fusion to the C-terminus was localized in
the perinuclear membrane as well being probed by the ABCA7
epitope and GFP ﬂuorescence [12]. Cell surface biotinylation
[4] and immunoﬂuorescence microscopy analysis of non-per-
meabilized cells with the antibody against the ﬁrst putative
extracellular domain of human ABCA7 (amino acids 45–549)
[5] conﬁrmed the cell surface expression of the ABCA7 protein.
The latter experiment also revealed that this domain is exposed
to the outside of the cell indicating the same topological
arrangement as ABCA1 [5,13,18]. Most of type II ABCA7
protein was found intracellularly localized when expressed in
HEK 293 cells [5] indicating that the N-terminal domain
is important for sorting ABCA7 protein to the plasma
membrane.5. Regulation
5.1. Transcriptional regulation
The predicted promoter regions of human and mouse
ABCA7 conserved two modules containing putative transcrip-
tion factor-binding sites. The sites are targets for either ubiqui-
tous transcription factors or liver- or lymphoid-speciﬁc
transcription factors [11]. No data are available on the contri-
bution of these regions to the promoter activity.
ABCA7 is assumed to be a sterol-regulated gene, because
mRNA and protein levels of human monocyte-derived macro-
phages were reportedly increased by adding acetyl-low-density
lipoprotein to the medium and decreased by HDL3 [10]. The
liver X receptor (LXR) and the retinoid X receptor (RXR)
are major transcriptional regulators of the ABCA1 gene [2].
However, the ABCA7 mRNA level in mouse peritoneal mac-
rophages was not aﬀected by an LXR agonist with and with-
out an RXR agonist [4]. The ABCA7 protein level of the
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by stimulation with free cholesterol and LXR/RXR agonists
[8].
We have recently found that ABCA7 mRNA level is regu-
lated by sterol responsive/regulatory element binding protein
1a and 2 in human and mouse ﬁbroblasts (Iwamoto et al.,
unpublished data). These ﬁndings should provide a new clue
to understand regulatory mechanism of gene expression and
biological roles of ABCA7.
5.2. Posttranscriptional regulation
Nothing has been reported for posttranscriptional regulation
of endogenous ABCA7. In the transfected cells, apoA-I and
protease inhibitor N-acetyl-Leu-Leu-norleucinal (ALLN) in-
creased the steady state level of human ABCA7-GFP protein
in HEK293 cells [6]. We have shown that apoA-I and ALLN
upregulate cellular ABCA1 protein level through inhibiting a
thiol protease, most likely calpain [19,20]. Therefore, there
might be a similar regulatory mechanism for ABCA7 protein
metabolism. Phorbol 12-myristate 13-acetate (PMA) treatment
of the same cells resulted in a slight increase of the ABCA7 pro-
tein but apoA-I-mediated cholesterol and phospholipid release
was signiﬁcantly inhibited. In contrast, in the ABCA1-express-
ing cells, both ABCA1 protein level and apoA-I-mediated lipid
release were signiﬁcantly upregulated by PMA. Go¨6976, an
inhibitor of Ca2+-dependent protein kinase C isoform(s),
reversed all these eﬀects of PMA. Thus, protein kinase C is
likely involved in posttranscriptional regulation of both ABC
proteins, and it seems to modulate the speciﬁc activity of
ABCA7 for release of cellular lipid and generation of HDL
in vitro [6].6. Functions
6.1. HDL generation
The physiological function of ABCA7 is unknown. Because
of the structural homology to ABCA1, and because of the factTable 1
ApoA-I-mediated lipid release by ABCA7
Cell cDNA Tag Expressiond Add





HEK293 ECRa Human GFP I –
HEK293 Human type II GFP T –
L929b Human GFP SM –
HEK293 Mouse – T –
– T –
– T –
293-EBNA-T Mouse – T –




CHOc Mouse – T –
aHEK293 cells expressing ecdysone receptor.
bParent cells are positive for apoA-I-mediated phospholipid release but nega
cParent cells are positive for apoA-I-mediated cholesterol and phospholipid
dI, S, SM, and T denote inducible, stable, mixture of stable clones, and tran
eND: not described.that many ABC transporters act as lipid transporters
[13,18,21], the study on the function of ABCA7 has been fo-
cused on cellular lipid metabolism. ABCA1 was identiﬁed as
a causative gene for familial HDL deﬁciency (Tangier disease)
and other genetic HDL deﬁciencies [22–26] resulting in the lack
of the apolipoprotein-mediated HDL generation from the
cellular lipid [27,28]. Thus ABCA7 was investigated for the
analogy to this type of reaction in the transfected cells [4–9]
(Table 1).
All the results agree that ABCA7 supports apolipoprotein-
mediated phospholipid release and that phospholipids are
the primary substrate for this ABCA7-mediated reaction.
ABCA7 expressed in several cell lines promoted phospholipid
release by lipid-free apolipoproteins such as apoA-I and apoA-
II in a time- and dose-dependent manner, similarly to ABCA1.
As was reported in ABCA1 [29], HEK293 cells expressing
mouse ABCA7 showed increased speciﬁc binding of apoA-I,
and covalent cross-linking studies revealed complex formation
of ABCA7 and apoA-I [4]. These data suggested that apoA-I
binds ABCA7 directly, or localizes very close to ABCA7 on
the cell surface. After normalization of cell surface protein
expression with Flag-tag, mouse ABCA7 was shown to have
the same ‘‘phospholipid transporter’’ activity [7] as ABCA1,
or 10–50% of the ABCA1 activity [8].
ABCA7 mediates cholesterol release much less than
phospholipid, though we claim it is low but positive by using
human ABCA7 without or with GFP-tag expressed in several
types of cell lines even in the absence of ABCA1 [5,6,9] and
others report negative [4,7] or no [8] data (Table 1). It is note-
worthy that type II ABCA7 protein, very little is localized in
plasma membrane, mediates neither cholesterol nor phospho-
lipid release [5].
According to our data, the released cholesterol/phospholipid
ratio from ABCA1-expressing cells is much higher than that
from ABCA7-expressing cells [6,9]. We have developed a
HEK 293 cell system with ecdysone-inducible human ABCA1
and ABCA7. While the cholesterol/phospholipid ratio in the















loading  ND [4]
BI expression  ND [4]
 ND [4]
tive for cholesterol release.
release.
sient, respectively.
Fig. 1. Lipoprotein analysis of the HDL particles generated from the ABCA1- and ABCA7-induced cells (taken from Ref. [9]). Ecdysone receptor-
expressing HEK293 cells with inducible human ABCA1-GFP (A–C) and inducible human ABCA7-GFP (D–F) were incubated without (A,D), with
low dose (B,E), and with high dose (C,F) of ponasterone A for induction. After 24-h incubation with 10 lg/ml apoA-I, medium was collected for
HPLC analysis. The concentration of cholesterol (red lines) and phospholipid (blue lines) in each fraction was measured.
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stant when the ABCA7 protein level was increased [9]. Analy-
ses of size distribution and lipid composition of the generated
HDL particles by a gel permeation HPLC system revealed that
the ABCA1-mediated reaction produced two types of HDL
particles, large particles with a high cholesterol/phospholipid
ratio and small particles with a low cholesterol/phospholipid
ratio (Fig. 1B). The ABCA7-mediated reaction generated
mostly the small particles (Fig. 1E). Induction of the ABC
transporters by ecdysone caused a dominant increase of the
large particles in the ABCA1-expressing cells and only the
small particles in the ABCA7-expressing cells (Fig. 1C and
F). Despite all these in vitro ﬁndings on the ABCA7-mediated
generation of HDL, it is clear that ABCA1, not ABCA7, is
essential to maintain the plasma HDL concentration from
the studies on Tangier disease patients and ABCA1 knockout
mice [2]. In addition, apoA-I-mediated cellular cholesterol and
phospholipid release were all unaﬀected in bone marrow-de-
rived macrophages prepared from ABCA7 knockout mice
[8], peritoneal macrophages from ABCA7 heterozygous mice
[7], and normal peritoneal macrophages treated with ABCA7
siRNA [7]. Therefore, the ABCA7-mediated lipid release
may not signiﬁcantly contribute to a source of plasma HDL.
However, it may still play an important role in cellular choles-
terol homeostasis in certain particular tissues including
macrophages.
6.2. Others
ABCA7 is also expressed in several cells other than the retic-
uloendothelial system. Platelets express high-levels of ABCA7
at least in mouse and rat [4,12]. As platelets secrete various li-
pid mediators including sphingosine 1-phosphate and lyso-
phosphatidic acid, possible functional integration of ABCA7
in the secretion mechanism of the mediators was suggested
[12].
HaCaT cells, a spontaneously immortalized human
keratinocyte cell line cells, and primary cultured normalhuman epidermal keratinocytes (NHEK cells) can be diﬀeren-
tiated by increased Ca2+ concentration in the medium. During
this diﬀerentiation period, the cellular ceramide concentration
increases. RT-PCR analysis of the cells found that ABCA7
mRNA increased 3 times from the undiﬀerentiated to the dif-
ferentiated stage of NHEK cells [30]. Expression of human
ABCA7 in HeLa cells resulted in an increase of intracellular
phospholipids compared to the mock-transfected cells (to
135%, 130%, and 115% in ceramide, phosphatidylserine, and
phosphatidylcholine, respectively) and an increase of cell sur-
face ceramide expression [30]. From these data, a potential role
of ABCA7 in epidermal lipid reorganization was proposed.
The ABCA7 protein level is high in mouse white adipose tis-
sue and is upregulated during diﬀerentiation of the mouse
preadipocyte cell line 3T3L1 to adipocytes, suggesting its po-
tential role in lipid transport in these cells [8]. In the diﬀerenti-
ated 3T3L1 cells, some ABCA7 protein is shown colocalized
with perilipin in the lipid droplet and microsomal fractions,
being diﬀerent from ABCA1 [8].7. Conclusions and perspectives
ABCA7 is a protein that has the highest homology to
ABCA1. ABCA7 mediates apolipoprotein-derived generation
of HDL similarly to ABCA1, suggesting that it may compen-
sate the function of ABCA1 for release of cellular lipid in a cer-
tain condition(s). However, it is obvious that ABCA7 does not
rescue the plasma HDL deﬁciency caused by the defect of
ABCA1 function, in either man or mouse. In addition, diﬀer-
ences between ABCA1 and ABCA7, especially in tissue distri-
bution proﬁle and transcriptional regulatory mechanism,
implicate that ABCA7 may have a more speciﬁc role(s) than
mimicking ABCA1. Studies on similarity and diﬀerence be-
tween ABCA1 and ABCA7 would provide us with more infor-
mation to address the questions for understanding functions of
these transporters.
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